Clinical trials
Recruiting Phase 1 Non-alcoholic Fatty Liver Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Columbia University | 2 |
| Eccogene | 2 |
| 1Globe Health Institute | 1 |
| Boehringer Ingelheim | 1 |
| Changchun Intellicrown Pharmaceutical Co. LTD | 1 |
| GlaxoSmithKline | 1 |
| Inipharm Australia Pty Ltd | 1 |
| Sunshine Lake Pharma Co., Ltd. | 1 |
| Tasly Biopharmaceuticals Co., Ltd. | 1 |
| University of California, San Francisco | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 13 |
| Fatty Liver | 2 |
| Hyperinsulinism | 2 |
| Insulin Resistance | 2 |
| Obesity | 2 |
| Prediabetic State | 2 |
| Diabetes Mellitus, Type 2 | 1 |
| Dyslipidemias | 1 |
| Overweight | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.